LBA62 Preoperative modified FOLFIRINOX (mFOLFIRINOX) with or without chemoradiation (CRT) in borderline resectable pancreatic cancer (BRPC): Results from the randomized phase II trial PANDAS/PRODIGE 44

ANNÉE

2024

AUTEURS

Lambert A, Bouche O, Ayav A, Bachet JB, Schwarz L, Piessen G, Vendrely V, Laurent V, Thibaudeau E, Miglianico L, Rinaldi Y, Hammel P, Conroy T

CONGRÈS/REVUE

ESMO

ÉTUDE

Localisation

LIEN PUBLICATIONS ASSOCIÉES